Morepen’s Money Moves: Pharma Giant Posts Robust ₹3.85 Billion Revenue, Profit Surprises

Morepen Laboratories has announced its financial results for the March 2025 quarter, reporting a total income of ₹3.85 billion (₹385 crore) and a net profit of ₹119.1 million (₹11.91 crore). The company continues to demonstrate resilience in revenue generation, with the latest quarter reflecting a stable performance in the face of industry headwinds.

 

Key Highlights:

Despite the softness in net profit, Morepen Laboratories’ ability to sustain revenue growth highlights its resilience and adaptability in a competitive market. Investors and stakeholders will be closely watching the company’s strategic initiatives aimed at improving margins and driving future profitability.

 

Sources: Moneycontrol, BlinkX, Kotak Securities